Young Adults Lead Psychedelic Use: What National Survey Data Reveals

This article examines the latest national survey data to understand the trends and demographics of psychedelic use among young adults in the United States, exploring who is using these substances and why their use is on the rise. 

Synopsis 

Recent data from national surveys reveals a significant trend: young adults are now the primary users of psychedelic substances in the United States. This article delves into the research to unpack this trend, exploring the demographics of young adult psychedelic users, the types of substances being used, and the potential reasons behind this increase. We will look at what the data says about the changing landscape of psychedelic use and what it might mean for the future of mental health and drug policy.

A Generational Shift in Psychedelic Use

The use of psychedelic substances has a long and complex history in the United States, from the counterculture movement of the 1960s to the current "psychedelic renaissance" in medicine and science. Today, we are witnessing another significant shift, this time in the demographics of who is using these substances. National survey data consistently shows that young adults, typically defined as those between the ages of 18 and 30, are now the largest group of psychedelic users.

This trend is not just a matter of idle curiosity; it has significant implications for public health, drug policy, and the future of mental health care. Understanding who is using psychedelics and why is crucial for developing effective harm reduction strategies, informing public education campaigns, and guiding the responsible integration of these substances into mainstream medicine.

The Data: What the Surveys Say

A 2023 study published in the journal Addiction by Katherine Keyes and Megan Patrick provides a detailed look at this trend. Their analysis of data from the Monitoring the Future study, a long-term study of substance use among American adolescents, college students, and young adults, found that the use of non-LSD hallucinogens (a category that includes psilocybin, or "magic mushrooms") nearly doubled among young adults aged 19-30 between 2018 and 2021. The study reported that the prevalence of past-year use of these substances increased from 3.4% in 2018 to 6.6% in 2021.

The study also shed light on the demographics of these young adult users. The researchers found that males were more likely to use non-LSD hallucinogens than females, and that use was more common among white individuals and those from higher socioeconomic backgrounds. These findings are consistent with other national surveys, which have also pointed to a similar demographic profile for psychedelic users.Another key source of information is the National Survey on Drug Use and Health (NSDUH), which provides national and state-level data on the use of tobacco, alcohol, and illicit drugs. While the user's provided link to the Rocky Mountain Poison & Drug Safety (RMPDS) survey was not a direct data source, it pointed to the general trend of increased use among young adults, a finding that is well-supported by the NSDUH data.

Why the Increase in Use?

There are likely multiple factors contributing to the rise in psychedelic use among young adults. One of the most significant is the growing body of scientific research on the therapeutic potential of these substances. The "psychedelic renaissance" has brought a new level of legitimacy to the study of psychedelics, and the media has been filled with stories about the potential of these substances to treat a range of mental health conditions, from depression and anxiety to PTSD and addiction.

This increased visibility has likely destigmatized the use of psychedelics for many young people, who may be more open to exploring their potential benefits. The growing interest in mental health and wellness among younger generations may also be a contributing factor. Many young adults are actively seeking out new and alternative approaches to mental health care, and psychedelics may be seen as a promising option.

The Implications for Public Health and Policy

The rising trend of psychedelic use among young adults presents both opportunities and challenges. On the one hand, it suggests that a growing number of individuals are exploring the potential of these substances for personal growth and healing. On the other hand, it also raises concerns about the potential for misuse and harm, particularly when these substances are used without proper guidance and support. It is crucial that we respond to this trend with a balanced and evidence-based approach. This includes:

•Public Education: Providing accurate and non-judgmental information about the potential risks and benefits of psychedelic use.

•Harm Reduction: Developing and promoting harm reduction strategies to help individuals who choose to use psychedelics do so as safely as possible.

•Responsible Regulation: Creating a regulatory framework that allows for safe and legal access to psychedelic therapy while also protecting public health.

•Further Research: Continuing to support scientific research into the therapeutic potential of psychedelics and the long-term effects of their use.

The Road Ahead

The data is clear: young adults are at the forefront of the current wave of psychedelic use. This trend is likely to continue as research into the therapeutic potential of these substances expands and they become more integrated into mainstream culture and medicine. By understanding the factors driving this trend and responding with thoughtful and evidence-based policies, we can help to ensure that the "psychedelic renaissance" unfolds in a way that is safe, responsible, and beneficial for all.

References

1.Keyes, K. M., & Patrick, M. E. (2023). Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021. Addiction, 118(12), 2449–2454. https://doi.org/10.1111/add.16259

2.Rocky Mountain Poison & Drug Safety. (2025). Natural Psychedelic & Psilocybin Facilitator Information. https://www.rmpds.org/nsiht

Disclaimer: Psychedelic Assisted Psychotherapy has not been approved by any regulatory agencies in the United States, and the safety and efficacy are still not formally established at the time of this writing.